Regulators in half a dozen European countries are now taking steps to enforce requirements that clinical trial sponsors make study results public, although three other countries have so far taken little to no action, a new analysis finds.
Specifically, Austria, Belgium, Denmark, Finland, Germany, Sweden and the Netherlands are in varying stages of prompting sponsors to publicize results of their past clinical trials. But there is no evidence that regulators in Italy, France, or Spain are doing the same, according to the analysis, which was conducted by several groups that advocate for greater clinical trial transparency.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
